These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18781193)

  • 1. The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.
    Qiu LX; Li RT; Zhang JB; Zhong WZ; Bai JL; Liu BR; Zheng MH; Qian XP
    Eur J Hum Genet; 2009 Feb; 17(2):244-9. PubMed ID: 18781193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.
    Deng QW; He BS; Pan YQ; Sun HL; Xu YQ; Gao TY; Li R; Song GQ; Wang SK
    Asian Pac J Cancer Prev; 2014; 15(8):3705-13. PubMed ID: 24870781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
    Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
    Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Association between the CDH1 -160C>A Polymorphism and Risk of Gastrointestinal Cancer - a Meta-Analysis.
    Sahami-Fard MH; Yazd EF; Khazaei Z; Neamatzadeh H
    Asian Pac J Cancer Prev; 2016; 17(5):2415-21. PubMed ID: 27268607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
    Wang Q; Gu D; Wang M; Zhang Z; Tang J; Chen J
    DNA Cell Biol; 2011 Jun; 30(6):395-400. PubMed ID: 21214416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E-cadherin (CDH1) -C160A polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Geng P; Chen Y; Ou J; Yin X; Sa R; Liang H
    DNA Cell Biol; 2012 Jun; 31(6):1070-7. PubMed ID: 22339265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
    Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
    Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.
    Bonilla C; Mason T; Long L; Ahaghotu C; Chen W; Zhao A; Coulibaly A; Bennett F; Aiken W; Tullock T; Coard K; Freeman V; Kittles RA
    Prostate; 2006 Apr; 66(5):546-56. PubMed ID: 16372334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
    Chen B; Zhou Y; Yang P; Liu L; Qin XP; Wu XT
    Cytokine; 2011 Aug; 55(2):266-73. PubMed ID: 21570316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
    Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
    Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 promoter polymorphism and stomach cancer susceptibility.
    Li YL; Tian Z; Zhang JB; Fu BY
    Mol Biol Rep; 2012 Feb; 39(2):1283-6. PubMed ID: 21625863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population.
    Lu Y; Xu YC; Shen J; Yu RB; Niu JY; Guo JT; Hu X; Shen HB
    World J Gastroenterol; 2005 Jan; 11(1):56-60. PubMed ID: 15609397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.
    Wang C; Tao W; Chen Q; Hu H; Wen XY; Han R
    Prostate; 2010 Feb; 70(2):170-8. PubMed ID: 19760631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.
    Ma YY; Wu WQ; Liu ZC; Yu XF; Guo K; He QW; Jiang SB; Shao QS; Tao HQ; Huang DS
    World J Surg Oncol; 2016 Jun; 14(1):169. PubMed ID: 27349965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between IL-18 -607 C/A Polymorphism and the Risk of Prostate Cancer: A Meta-Analysis of Case-Control Studies.
    Yuanyuan G; Xue Y; Yachao L; Xiao F; Xu C
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1595-1602. PubMed ID: 31244277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.
    Sun N; Chen J; Hu G; Chen X; Jiang J; Zhang L; Wu H
    Crit Rev Eukaryot Gene Expr; 2017; 27(4):347-354. PubMed ID: 29283329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.
    Mao C; Qiu LX; Zhan P; Xue K; Ding H; Du FB; Li J; Chen Q
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):975-9. PubMed ID: 20012093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
    Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
    Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.
    Wang GY; Lu CQ; Zhang RM; Hu XH; Luo ZW
    Am J Epidemiol; 2008 Jan; 167(1):7-14. PubMed ID: 17971340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.